Completed NA INTERVENTIONAL 2-arm NCT04698486

Hepatic and Cardiac Metabolic Flexibility in Subjects With T2DM With and Without NAFLD

Investigation of Hepatic and Cardiac Fatty Acid Metabolism in Patients With Type 2 Diabetes Mellitus With and Without Non-alcoholic Fatty Liver Disease

Sponsor: Danish Diabetes Academy

Conditions NAFLD - Non-Alcoholic Fatty Liver Disease Type 2 Diabetes

Interventions Hyperinsulinemic euglycaemic clamp

Updated 5 times since 2021 Last updated: May 23, 2022 Started: Jul 3, 2020 Primary completion: Dec 1, 2021 Completion: Dec 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates NAFLD - Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes and is currently completed. Danish Diabetes Academy leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Mar 2021 — Jun 2022 [monthly]

Recruiting NA
Feb 2021 — Mar 2021 [monthly]

Recruiting NA

First recorded

Jul 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Danish Diabetes Academy
University of Aarhus

Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aarhus N, Denmark